{"transactions":[{"id":1268013,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-14T23:01:32.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing February 28, 2025."}],"balance_after":27000,"derivative":{"exercise_price":2.3,"expiration_date":"2035-02-04","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001437749-25-004073","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774925004073/rdgdoc.xml","form_type":"4"}},{"id":1669914,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-26T23:43:25.000Z","date":"2024-01-26","kind":"grant","planned":false,"acquired":true,"shares":55721,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2024."}],"balance_after":55721,"derivative":{"exercise_price":9.05,"expiration_date":"2034-01-26","underlying":"Common Stock","underlying_shares":55721},"source":{"system":"sec-edgar","filing":"0001437749-24-002344","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774924002344/rdgdoc.xml","form_type":"4"}},{"id":1780426,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"officer":true,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-15T23:02:02.000Z","date":"2023-09-15","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing September 30, 2023."}],"balance_after":16000,"derivative":{"exercise_price":5.33,"expiration_date":"2033-09-15","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001437749-23-026079","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923026079/rdgdoc.xml","form_type":"4"}},{"id":2033800,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Restricted Stock Unit","published_at":"2023-02-03T21:13:40.000Z","date":"2023-01-31","kind":"exercise","acquired":false,"shares":327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On January 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $796.18 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.58.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $796.18 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.58.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $796.18 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.58.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":327},"source":{"system":"sec-edgar","filing":"0001437749-23-002473","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923002473/rdgdoc.xml","form_type":"4"}},{"id":2033799,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-03T21:13:40.000Z","date":"2023-01-31","kind":"disposition_to_issuer","acquired":false,"shares":121,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $796.18 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.58.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $796.18 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.58.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1616,"source":{"system":"sec-edgar","filing":"0001437749-23-002473","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923002473/rdgdoc.xml","form_type":"4"}},{"id":2033798,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2023-02-03T21:13:40.000Z","date":"2023-01-31","kind":"exercise","acquired":true,"shares":327,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 31, 2023 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $796.18 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.58.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1737,"source":{"system":"sec-edgar","filing":"0001437749-23-002473","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774923002473/rdgdoc.xml","form_type":"4"}},{"id":2127485,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Restricted Stock Unit","published_at":"2022-11-02T21:15:34.000Z","date":"2022-10-31","kind":"exercise","acquired":false,"shares":327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On October 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $580.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.80.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On October 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $580.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.80.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On October 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $580.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.80.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":327,"derivative":{"underlying":"Common Stock","underlying_shares":327},"source":{"system":"sec-edgar","filing":"0001437749-22-025572","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922025572/rdgdoc.xml","form_type":"4"}},{"id":2127484,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-11-02T21:15:34.000Z","date":"2022-10-31","kind":"disposition_to_issuer","acquired":false,"shares":121,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $580.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.80.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $580.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.80.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1410,"source":{"system":"sec-edgar","filing":"0001437749-22-025572","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922025572/rdgdoc.xml","form_type":"4"}},{"id":2127483,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-11-02T21:15:34.000Z","date":"2022-10-31","kind":"exercise","acquired":true,"shares":327,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $580.75 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $4.80.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1531,"source":{"system":"sec-edgar","filing":"0001437749-22-025572","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922025572/rdgdoc.xml","form_type":"4"}},{"id":2196299,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Restricted Stock Unit","published_at":"2022-08-03T21:52:47.000Z","date":"2022-08-01","kind":"exercise","acquired":false,"shares":327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On August 1, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $787.71 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.51.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer.\n\nAll share, per share, and share-based amounts reflect the Issuer's 1-for-50 reverse stock split implemented April 18, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On August 1, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $787.71 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.51.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer.\n\nAll share, per share, and share-based amounts reflect the Issuer's 1-for-50 reverse stock split implemented April 18, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On August 1, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $787.71 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.51.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer.\n\nAll share, per share, and share-based amounts reflect the Issuer's 1-for-50 reverse stock split implemented April 18, 2022."}],"balance_after":654,"derivative":{"underlying":"Common Stock","underlying_shares":327},"source":{"system":"sec-edgar","filing":"0001437749-22-018666","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922018666/rdgdoc.xml","form_type":"4"}},{"id":2196298,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-08-03T21:52:47.000Z","date":"2022-08-01","kind":"disposition_to_issuer","acquired":false,"shares":121,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On August 1, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $787.71 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.51.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer.\n\nAll share, per share, and share-based amounts reflect the Issuer's 1-for-50 reverse stock split implemented April 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 1, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $787.71 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.51.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer.\n\nAll share, per share, and share-based amounts reflect the Issuer's 1-for-50 reverse stock split implemented April 18, 2022."}],"balance_after":1204,"source":{"system":"sec-edgar","filing":"0001437749-22-018666","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922018666/rdgdoc.xml","form_type":"4"}},{"id":2196297,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-08-03T21:52:47.000Z","date":"2022-08-01","kind":"exercise","acquired":true,"shares":327,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 1, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $787.71 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.51.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer.\n\nAll share, per share, and share-based amounts reflect the Issuer's 1-for-50 reverse stock split implemented April 18, 2022."}],"balance_after":1325,"source":{"system":"sec-edgar","filing":"0001437749-22-018666","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922018666/rdgdoc.xml","form_type":"4"}},{"id":2284949,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Restricted Stock Unit","published_at":"2022-05-03T22:24:54.000Z","date":"2022-05-02","kind":"exercise","acquired":false,"shares":327,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 2, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $842.09 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.96.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On May 2, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $842.09 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.96.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On May 2, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $842.09 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.96.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":981,"derivative":{"underlying":"Common Stock","underlying_shares":327},"source":{"system":"sec-edgar","filing":"0001437749-22-010718","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922010718/rdgdoc.xml","form_type":"4"}},{"id":2284948,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Sock","published_at":"2022-05-03T22:24:54.000Z","date":"2022-05-02","kind":"disposition_to_issuer","acquired":false,"shares":121,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On May 2, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $842.09 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.96.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 2, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $842.09 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.96.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":998,"source":{"system":"sec-edgar","filing":"0001437749-22-010718","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922010718/rdgdoc.xml","form_type":"4"}},{"id":2284947,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-05-03T22:24:54.000Z","date":"2022-05-02","kind":"exercise","acquired":true,"shares":327,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 2, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 206 Shares and (ii) $842.09 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $6.96.  The remainder of the award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":1119,"source":{"system":"sec-edgar","filing":"0001437749-22-010718","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922010718/rdgdoc.xml","form_type":"4"}},{"id":2295064,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Series C Convertible Preferred Stock","published_at":"2022-04-19T21:18:11.000Z","date":"2022-04-18","kind":"exercise","acquired":false,"shares":100,"price":25,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Series C Shares\"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement.  On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the \"Certificate of Designation\"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."},{"field":"shares","element":"transactionShares","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Series C Shares\"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement.  On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the \"Certificate of Designation\"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Series C Shares\"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement.  On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the \"Certificate of Designation\"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."}],"balance_after":0,"derivative":{"exercise_price":25,"underlying":"Common Stock","underlying_shares":100},"source":{"system":"sec-edgar","filing":"0001437749-22-009234","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922009234/rdgdoc.xml","form_type":"4"}},{"id":2295063,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-04-19T21:18:11.000Z","date":"2022-04-18","kind":"exercise","acquired":true,"shares":100,"price":25,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Series C Shares\"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement.  On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the \"Certificate of Designation\"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation."},{"field":"shares","element":"transactionShares","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As previously announced, on March 18, 2022, the Reporting Person purchased 100 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Series C Shares\"), from the Issuer at a purchase price of $25.00 per Series C Share in a private placement.  On April 18, 2022, in accordance with Section 8(a) of the Certificate of Designation of Preferences, Rights, and Limitations of the Series C Convertible Preferred Stock (the \"Certificate of Designation\"), the Issuer delivered to the Reporting Person written notice of the Mandatory Conversion (as defined in the Certificate of Designations) of all outstanding Series C Shares into an equivalent number of shares of the Company's common stock, par value $0.001, pursuant to and in accordance with the terms of the Certificate of Designation."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"All share and per share amounts have been adjusted to reflect the Issuer's 1-for-50 reverse stock split, effective April 18, 2022."}],"balance_after":792,"source":{"system":"sec-edgar","filing":"0001437749-22-009234","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922009234/rdgdoc.xml","form_type":"4"}},{"id":2322018,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Series C Convertible Preferred Stock","published_at":"2022-03-22T11:30:26.000Z","date":"2022-03-18","kind":"purchase","acquired":true,"shares":5000,"price":0.5,"value":2500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On March 18, 2022, the Reporting Person purchased 5,000 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Shares\"), from the Issuer at a purchase price of $0.50 per Share in a private placement.  The Shares have no voting rights, other than (i) each Share will be counted on an as converted basis, together with the Issuer's common stock as a single class, for purposes of determining the presence of a quorum at any meeting of the Issuer's stockholders at which a proposal related to a reverse stock split of the Issuer's common stock (a \"Reverse Stock Split\") will be voted upon, (ii) each Share is entitled to 80,000 votes on matters related to a Reverse Stock Split, provided that such votes must be cast For and Against each proposal on a \"mirrored\" basis proportional to the vote of the Issuer's common stockholders, and (iii) the right to vote as a class on certain specified matters directly related to the preferences, rights, and limitations of the Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On March 18, 2022, the Reporting Person purchased 5,000 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Shares\"), from the Issuer at a purchase price of $0.50 per Share in a private placement.  The Shares have no voting rights, other than (i) each Share will be counted on an as converted basis, together with the Issuer's common stock as a single class, for purposes of determining the presence of a quorum at any meeting of the Issuer's stockholders at which a proposal related to a reverse stock split of the Issuer's common stock (a \"Reverse Stock Split\") will be voted upon, (ii) each Share is entitled to 80,000 votes on matters related to a Reverse Stock Split, provided that such votes must be cast For and Against each proposal on a \"mirrored\" basis proportional to the vote of the Issuer's common stockholders, and (iii) the right to vote as a class on certain specified matters directly related to the preferences, rights, and limitations of the Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On March 18, 2022, the Reporting Person purchased 5,000 shares of Series C Convertible Preferred Stock, par value $0.001 per share (the \"Shares\"), from the Issuer at a purchase price of $0.50 per Share in a private placement.  The Shares have no voting rights, other than (i) each Share will be counted on an as converted basis, together with the Issuer's common stock as a single class, for purposes of determining the presence of a quorum at any meeting of the Issuer's stockholders at which a proposal related to a reverse stock split of the Issuer's common stock (a \"Reverse Stock Split\") will be voted upon, (ii) each Share is entitled to 80,000 votes on matters related to a Reverse Stock Split, provided that such votes must be cast For and Against each proposal on a \"mirrored\" basis proportional to the vote of the Issuer's common stockholders, and (iii) the right to vote as a class on certain specified matters directly related to the preferences, rights, and limitations of the Shares."}],"balance_after":5000,"derivative":{"exercise_price":0.5,"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001437749-22-006871","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922006871/rdgdoc.xml","form_type":"4"}},{"id":2417263,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Restricted Stock Unit","published_at":"2022-02-03T01:18:58.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":16350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On November 1, 2021 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 10,301 Shares and (ii) $2,722.05 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.45.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 1, 2021 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 10,301 Shares and (ii) $2,722.05 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.45.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On November 1, 2021 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 10,301 Shares and (ii) $2,722.05 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.45.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":81750,"derivative":{"underlying":"Common Stock","underlying_shares":16350},"source":{"system":"sec-edgar","filing":"0001437749-22-002263","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922002263/rdgdoc.xml","form_type":"4/A","original_submission_date":"2021-11-03"}},{"id":2417262,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-03T01:18:58.000Z","date":"2021-11-01","kind":"disposition_to_issuer","acquired":false,"shares":6049,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On November 1, 2021 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 10,301 Shares and (ii) $2,722.05 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.45.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 1, 2021 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 10,301 Shares and (ii) $2,722.05 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.45.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":24301,"source":{"system":"sec-edgar","filing":"0001437749-22-002263","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922002263/rdgdoc.xml","form_type":"4/A","original_submission_date":"2021-11-03"}},{"id":2417261,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-03T01:18:58.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":16350,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 1, 2021 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 10,301 Shares and (ii) $2,722.05 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.45.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":30350,"source":{"system":"sec-edgar","filing":"0001437749-22-002263","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922002263/rdgdoc.xml","form_type":"4/A","original_submission_date":"2021-11-03"}},{"id":2417260,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Restricted Stock Unit","published_at":"2022-02-03T01:18:20.000Z","date":"2022-01-31","kind":"exercise","acquired":false,"shares":16350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On January 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 10,301 Shares and (ii) $1,633.23 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.27.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On January 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 10,301 Shares and (ii) $1,633.23 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.27.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On January 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 10,301 Shares and (ii) $1,633.23 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.27.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":65400,"derivative":{"underlying":"Common Stock","underlying_shares":16350},"source":{"system":"sec-edgar","filing":"0001437749-22-002262","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922002262/rdgdoc.xml","form_type":"4"}},{"id":2417259,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-03T01:18:20.000Z","date":"2022-01-31","kind":"disposition_to_issuer","acquired":false,"shares":6049,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On January 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 10,301 Shares and (ii) $1,633.23 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.27.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 10,301 Shares and (ii) $1,633.23 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.27.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":34602,"source":{"system":"sec-edgar","filing":"0001437749-22-002262","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922002262/rdgdoc.xml","form_type":"4"}},{"id":2417258,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2022-02-03T01:18:20.000Z","date":"2022-01-31","kind":"exercise","acquired":true,"shares":16350,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 31, 2022 (the \"Vesting Date\"), in connection with the vesting of previously awarded restricted stock units (\"RSUs\"), each RSU representing a contingent right to receive one share of the Issuer's common stock (a \"Share\"), the Reporting Person became entitled to receive, in accordance with Section 8.7 of the Issuer's 2015 Equity Incentive Plan (as amended, the \"Plan\") and the terms of the underlying award agreement,  (i) 10,301 Shares and (ii) $1,633.23 in cash, representing the Fair Market Value (as defined in the 2015 Equity Plan) of the remaining portion of the award vested on the Vesting Date, based on the closing sale price of one Share reported by the NASDAQ Stock Market on such date of $0.27.  The remainder of award will continue to vest in tri-monthly installments, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":40651,"source":{"system":"sec-edgar","filing":"0001437749-22-002262","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922002262/rdgdoc.xml","form_type":"4"}},{"id":2421398,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-31T11:02:12.000Z","date":"2022-01-27","kind":"grant","acquired":true,"shares":764357,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing January 31, 2022."}],"balance_after":764357,"derivative":{"exercise_price":0.24,"expiration_date":"2032-01-27","underlying":"Common Stock","underlying_shares":764357},"source":{"system":"sec-edgar","filing":"0001437749-22-001911","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774922001911/rdgdoc.xml","form_type":"4"}},{"id":2527121,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Restricted Stock Units","published_at":"2021-11-04T01:07:50.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":16350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On November 1, 2021, the Reporting Person received 16,350 shares in connection with the vesting of previously awarded restricted stock units, each unit representing a contingent right to receive one share of the Issuer's common stock.  Subject to the Reporting Person's continuing service with the Issuer, the remaining restricted stock units will vest in equal, tri-monthly installments."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On November 1, 2021, the Reporting Person received 16,350 shares in connection with the vesting of previously awarded restricted stock units, each unit representing a contingent right to receive one share of the Issuer's common stock.  Subject to the Reporting Person's continuing service with the Issuer, the remaining restricted stock units will vest in equal, tri-monthly installments."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On November 1, 2021, the Reporting Person received 16,350 shares in connection with the vesting of previously awarded restricted stock units, each unit representing a contingent right to receive one share of the Issuer's common stock.  Subject to the Reporting Person's continuing service with the Issuer, the remaining restricted stock units will vest in equal, tri-monthly installments."}],"balance_after":81750,"derivative":{"underlying":"Common Stock","underlying_shares":16350},"source":{"system":"sec-edgar","filing":"0001437749-21-025138","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774921025138/rdgdoc.xml","form_type":"4"}},{"id":2527120,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2021-11-04T01:07:50.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":16350,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On November 1, 2021, the Reporting Person received 16,350 shares in connection with the vesting of previously awarded restricted stock units, each unit representing a contingent right to receive one share of the Issuer's common stock.  Subject to the Reporting Person's continuing service with the Issuer, the remaining restricted stock units will vest in equal, tri-monthly installments."}],"balance_after":30350,"source":{"system":"sec-edgar","filing":"0001437749-21-025138","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774921025138/rdgdoc.xml","form_type":"4"}},{"id":2809459,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-05T00:33:40.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":161139,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The amount reported reflects the maximum number of shares of common stock underlying the award that may vest based upon the achievement of specified performance metrics. The vesting of such shares is contingent upon the timely and successful achievement during the year ending December 31, 2021 of certain performance milestones related to the Issuer's planned clinical trials, with the vesting of one-third (1/3) of the total shares tied to each such milestone. If any such milestone is achieved, one-third (1/3) of the shares tied to such milestone (i.e. one-ninth (1/9) of the total shares underlying the award) will vest immediately and the remainder of the shares tied to such milestone (i.e. two-ninths (2/9) of the total shares underlying the award) will vest in 24 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 24-month period commencing January 31, 2022. In order for all shares underlying the award to vest, all three milestones mus"}],"balance_after":161139,"derivative":{"exercise_price":1.11,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":161139},"source":{"system":"sec-edgar","filing":"0001437749-21-005060","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774921005060/rdgdoc.xml","form_type":"4"}},{"id":2809458,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-03-05T00:33:40.000Z","date":"2021-03-01","kind":"grant","acquired":true,"shares":53713,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of common stock underlying the award will vest in 36 equal (or as near equal as possible) monthly installments on the last calendar day of each month over a 36-month period commencing March 31, 2021."}],"balance_after":53713,"derivative":{"exercise_price":1.11,"expiration_date":"2031-03-01","underlying":"Common Stock","underlying_shares":53713},"source":{"system":"sec-edgar","filing":"0001437749-21-005060","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774921005060/rdgdoc.xml","form_type":"4"}},{"id":2975868,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2020-11-19T02:15:54.000Z","date":"2020-11-16","kind":"purchase","acquired":true,"shares":14000,"price":0.66,"value":9240.0,"ownership":{"direct":true},"balance_after":14000,"source":{"system":"sec-edgar","filing":"0001437749-20-024187","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774920024187/rdgdoc.xml","form_type":"4"}},{"id":3033453,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-09-11T22:56:53.000Z","date":"2020-09-08","kind":"grant","acquired":true,"shares":475000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On September 8, 2020, the Reporting person was granted an option to purchase 475,000 shares of the Company's common stock; provided, however, that the Reporting Person's continued holding of the grant is contingent upon the annual automatic increase in the share pool under the Issuer's 2015 Equity Incentive Plan on January 1, 2021 being sufficient to cover all shares of the Issuer's common stock underlying the grant. Subject to the foregoing, one-twelfth of the option grant will vest on January 1, 2021, and thereafter the grant will vest monthly in substantially equal 1/36th increments on the last day of each month, beginning on January 31, 2021 through the last day of the month containing the third anniversary of the grant date, subject to the Reporting Person's continued employment with the Company through the applicable vesting date."}],"balance_after":475000,"derivative":{"exercise_price":0.79,"expiration_date":"2030-09-08","underlying":"Common Stock","underlying_shares":475000},"source":{"system":"sec-edgar","filing":"0001437749-20-019648","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774920019648/rdgdoc.xml","form_type":"4"}},{"id":3105801,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-18T20:53:17.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":61300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest in 12 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a one-year period beginning on June 17, 2020."}],"balance_after":61300,"derivative":{"exercise_price":1,"expiration_date":"2030-06-17","underlying":"Common Stock","underlying_shares":61300},"source":{"system":"sec-edgar","filing":"0001437749-20-013422","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774920013422/rdgdoc.xml","form_type":"4"}},{"id":3312728,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true}}],"security":"Restricted Stock Unit","published_at":"2020-01-13T22:11:31.000Z","date":"2020-01-07","kind":"grant","acquired":true,"shares":98100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the restricted stock units vest in 6 equal (or as nearly equal as possible) quarterly installments on the last calendar day of each quarter over an 18-month period beginning on July 1, 2021."}],"balance_after":98100,"derivative":{"exercise_price":0.51,"expiration_date":"2022-12-31","underlying":"Common Stock","underlying_shares":98100},"source":{"system":"sec-edgar","filing":"0001437749-20-000552","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774920000552/rdgdoc.xml","form_type":"4"}},{"id":3312727,"issuer":{"id":7338,"kind":"organization","name":"CervoMed Inc."},"owners":[{"id":83224,"kind":"person","name":"Cobuzzi Robert Joseph Jr.","position":1,"cik":"0001799838","reported_name":"Cobuzzi Robert Joseph Jr.","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-13T22:11:31.000Z","date":"2020-01-07","kind":"grant","acquired":true,"shares":118600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the options vest in 18 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over an 18-month period beginning immediately."}],"balance_after":118600,"derivative":{"exercise_price":0.42,"expiration_date":"2021-06-30","underlying":"Common Stock","underlying_shares":118600},"source":{"system":"sec-edgar","filing":"0001437749-20-000552","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1053691/000143774920000552/rdgdoc.xml","form_type":"4"}}]}